{"disease":{"id":"shigella","name":"shigella"},"drugs":{"marketed":[{"drug_id":"doxycycline","indication_name":"Infections caused by Shigella species","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06047821","title":"Enterics for Global Health (EFGH)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9800,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT06838195","title":"Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8000,"lead_sponsor_name":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT03778125","title":"Multidrug Resistant Shigella Infection in Bangladesh","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT04694235","title":"Egg Intervention During Pregnancy in Indonesia","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":702,"lead_sponsor_name":"SEAMEO Regional Centre for Food and Nutrition","has_results":false},{"nct_id":"NCT03854929","title":"Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":364,"lead_sponsor_name":"Oxford University Clinical Research Unit, Vietnam","has_results":false},{"nct_id":"NCT01336699","title":"Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02676895","title":"A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT07049159","title":"Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"Eveliqure Biotechnologies GmbH","has_results":false},{"nct_id":"NCT04242264","title":"Phase 2 Shigella Vaccine and Challenge","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT07205926","title":"First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Inventprise Inc.","has_results":false},{"nct_id":"NCT04078022","title":"Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":true},{"nct_id":"NCT04634513","title":"Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":true},{"nct_id":"NCT03038243","title":"Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"PATH","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}